Journal article
Chemotherapy for Relapsed Small Cell Lung Cancer: A Systematic Review and Practice Guideline
Abstract
PURPOSE: This clinical practice guideline, based on a systematic review, evaluates chemotherapy options for patients with relapsed small cell lung cancer (SCLC).
METHODS: Relevant randomized trials and meta-analyses were identified through a systematic search of the literature. External feedback was obtained from practitioners in Ontario, and the guideline was approved by the provincial lung cancer disease site group.
Authors
Cheng S; Evans WK; Stys-Norman D; Shepherd FA; Care TLCDSGOCCOPIE-B
Journal
Journal of Thoracic Oncology, Vol. 2, No. 4, pp. 348–354
Publisher
Elsevier
Publication Date
April 2007
DOI
10.1097/01.jto.0000263720.15062.51
ISSN
1556-0864
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Administration, OralAdultAgedAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Small CellClinical Trials, Phase III as TopicEtoposideFemaleHumansInfusions, IntravenousLomustineLung NeoplasmsMaleMaximum Tolerated DoseMelphalanMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingOntarioPractice Guidelines as TopicPrognosisRandomized Controlled Trials as TopicSalvage TherapySurvival AnalysisTopotecan